Sage Therapeutic Stock Options Expiring on 21st of February
| SAGE Stock | USD 7.35 0.10 1.38% |
Sage Therapeutic's latest option contracts expiring on February 21st 2025 are carrying combined implied volatility of 3.29 with a put-to-call open interest ratio of 0.83 over 18 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on February 21st 2025. The total put volume is at 20.0, with calls trading at the volume of 12.0. This yields a 1.67 put-to-call volume ratio.
Open Interest Against February 21st 2025 Option Contracts
2025-02-21
The chart above shows Sage Therapeutic's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Sage Therapeutic's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Sage Therapeutic's option, there is no secondary market available for investors to trade.
Sage Therapeutic's stock options are financial instruments that give investors the right to buy or sell shares of Sage Therapeutic common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Sage stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Sage Therapeutic's stock price goes up or down, the stock options follow.
The current year's Other Stockholder Equity is expected to grow to about 4.1 B, whereas Total Stockholder Equity is forecasted to decline to about 802.6 M. Sage Therapeutic In The Money Call Balance
When Sage Therapeutic's strike price is surpassing the current stock price, the option contract against Sage Therapeutic stock is said to be in the money. When it comes to buying Sage Therapeutic's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Sage Therapeutic are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Sage Current Options Market Mood
Sage Therapeutic's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Sage Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Sage Therapeutic's options investors are not very successful. Sage Therapeutic's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Sage contract
Base on the Rule 16, the options market is currently suggesting that Sage Therapeutic will have an average daily up or down price movement of about 0.21% per day over the life of the 2025-02-21 option contract. With Sage Therapeutic trading at USD 7.35, that is roughly USD 0.0151. If you think that the market is fully incorporating Sage Therapeutic's daily price movement you should consider buying Sage Therapeutic options at the current volatility level of 3.29%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Sage |
Sage Therapeutic Option Chain
When Sage Therapeutic's strike price is surpassing the current stock price, the option contract against Sage Therapeutic stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Sage Therapeutic's option chain is a display of a range of information that helps investors for ways to trade options on Sage. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Sage. It also shows strike prices and maturity days for a Sage Therapeutic against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | SAGE250221C00002500 | 1 | 2.5 | 2.5 - 7.2 | 3.1 | In |
Call | SAGE250221C00005000 | 769 | 5.0 | 0.45 - 3.1 | 2.05 | In |
Call | SAGE250221C00007500 | 1597 | 7.5 | 0.2 - 0.3 | 0.25 | Out |
Call | SAGE250221C00010000 | 1858 | 10.0 | 0.0 - 0.2 | 0.09 | Out |
Call | SAGE250221C00012500 | 67 | 12.5 | 0.0 - 0.15 | 0.1 | Out |
Call | SAGE250221C00015000 | 28 | 15.0 | 0.0 - 1.5 | 0.02 | Out |
Call | SAGE250221C00017500 | 15 | 17.5 | 0.0 - 2.05 | 0.04 | Out |
Call | SAGE250221C00020000 | 1 | 20.0 | 0.0 - 2.15 | 0.05 | Out |
Call | SAGE250221C00022500 | 15 | 22.5 | 0.0 - 0.05 | 0.05 | Out |
Put | SAGE250221P00002500 | 0 | 2.5 | 0.0 - 0.05 | 0.05 | |
Put | SAGE250221P00005000 | 3256 | 5.0 | 0.0 - 0.05 | 0.05 | Out |
Put | SAGE250221P00007500 | 364 | 7.5 | 0.0 - 0.5 | 0.4 | In |
Put | SAGE250221P00010000 | 0 | 10.0 | 0.6 - 4.7 | 3.1 | In |
Put | SAGE250221P00012500 | 2 | 12.5 | 3.0 - 7.2 | 4.9 | In |
Put | SAGE250221P00015000 | 0 | 15.0 | 5.6 - 9.7 | 5.6 | In |
Put | SAGE250221P00017500 | 0 | 17.5 | 8.1 - 12.2 | 8.1 | In |
Put | SAGE250221P00020000 | 0 | 20.0 | 10.6 - 14.7 | 10.6 | In |
Put | SAGE250221P00022500 | 0 | 22.5 | 13.0 - 17.3 | 13.0 | In |
Sage Therapeutic Market Cap Over Time
Market Cap |
| Timeline |
Sage Total Stockholder Equity
Total Stockholder Equity |
|
Sage Therapeutic Corporate Management
| Maren Killackey | Senior Relation | Profile | |
| Jim Doherty | Chief Officer | Profile | |
| Aaron MD | Medical Development | Profile | |
| Christopher Benecchi | Chief Officer | Profile | |
| Laura MD | Chief Officer | Profile | |
| Heinrich Schlieker | Senior Operations | Profile | |
| Albert Robichaud | Chief Scientific Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sage Therapeutic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For information on how to trade Sage Stock refer to our How to Trade Sage Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sage Therapeutic. If investors know Sage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sage Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.57) | Revenue Per Share | Quarterly Revenue Growth 3.371 | Return On Assets | Return On Equity |
The market value of Sage Therapeutic is measured differently than its book value, which is the value of Sage that is recorded on the company's balance sheet. Investors also form their own opinion of Sage Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Sage Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sage Therapeutic's market value can be influenced by many factors that don't directly affect Sage Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sage Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sage Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sage Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.